Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagn ...Middle East

The independent data monitoring committee (IDMC) has recommended continuation of CLINGLIO without modification after its assessment of LAM561 interim efficacy in newly diagnosed Glioblastoma. This follows the previous recommendation in relation to safety. CLINGLIO remains on track to have...

Hence then, the article about laminar pharmaceuticals s a receives recommendation from the independent data monitoring committee to advance to the next stage of clinglio the phase 2b 3 clinical trial of lam561 in combination with rt and tmz for adults with newly diagn was published today ( Wednesday 06/03/2024 - 03:48 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagn )

Also on site :

• Country Icon Carrie Underwood’s Latest Career Announcement May Leave Fans Disappointed
• EU must stop funding Kiev after Zelensky’s ‘insults’ – Italian MP
• Leonardo DiCaprio Reacts to Co-Star's Oscar Nomination Snub